| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR4M2 TAS2R4 TAS2R9 DRD1 DRD2 OR5AC1 DRD5 ADRB2 ADRB3 OR2AT4 TAS2R33 OR4A16 OR5L1 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 OR1F2P TACR2 OR8U3 CALCRL OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 GRM6 OR5AR1 CHRM4 GRPR OR51B2 OR4M2B OR8B3 OR4D2 | 1.81e-30 | 884 | 65 | 35 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR4M2 TAS2R4 TAS2R9 DRD1 DRD2 OR5AC1 DRD5 ADRB2 ADRB3 OR2AT4 TAS2R33 OR4A16 OR5L1 GLRA2 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 OR1F2P TACR2 OR8U3 CALCRL OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 GRM6 OR5AR1 CHRM4 GRPR OR51B2 OR4M2B OR8B3 OR4D2 | 1.94e-25 | 1353 | 65 | 36 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 3.61e-18 | 431 | 65 | 20 | GO:0004984 |
| GeneOntologyMolecularFunction | odorant binding | 3.03e-10 | 127 | 65 | 9 | GO:0005549 | |
| GeneOntologyMolecularFunction | catecholamine binding | 3.94e-10 | 13 | 65 | 5 | GO:1901338 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 3.28e-07 | 5 | 65 | 3 | GO:0004952 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A1 SLC6A2 LRRC8E LRRC8C GPR89B SLC9A4 SLC9A1 ABCA12 ABCA13 GLRA2 GPR89A SLC36A3 ATP13A3 ATP9A LMBRD1 SLC35A5 KCNH5 | 5.10e-07 | 1289 | 65 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.93e-07 | 151 | 65 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | dopamine binding | 1.14e-06 | 7 | 65 | 3 | GO:0035240 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A1 SLC6A2 LRRC8E LRRC8C GPR89B SLC9A4 SLC9A1 ABCA12 ABCA13 GLRA2 GPR89A SLC36A3 ATP13A3 SLC35A5 KCNH5 | 4.34e-06 | 1180 | 65 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.52e-06 | 75 | 65 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A1 SLC6A2 LRRC8E LRRC8C GPR89B SLC9A4 SLC9A1 GLRA2 GPR89A SLC36A3 ATP13A3 KCNH5 | 8.22e-06 | 793 | 65 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gs | 1.04e-05 | 2 | 65 | 2 | GO:0001588 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.15e-05 | 43 | 65 | 4 | GO:0001965 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.85e-05 | 100 | 65 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.14e-05 | 103 | 65 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A1 SLC6A2 SLC9A4 SLC9A1 ABCA12 ABCA13 SLC36A3 ATP13A3 SLC35A5 | 2.29e-05 | 477 | 65 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | bradykinin receptor binding | 3.12e-05 | 3 | 65 | 2 | GO:0031711 | |
| GeneOntologyMolecularFunction | norepinephrine binding | 6.23e-05 | 4 | 65 | 2 | GO:0051380 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor activity | 6.23e-05 | 4 | 65 | 2 | GO:0004939 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 7.29e-05 | 133 | 65 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 9.11e-05 | 27 | 65 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 9.29e-05 | 140 | 65 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.68e-04 | 33 | 65 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 3.21e-04 | 41 | 65 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 3.70e-04 | 9 | 65 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 3.70e-04 | 9 | 65 | 2 | GO:0005225 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.00e-04 | 296 | 65 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 4.37e-04 | 301 | 65 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 4.62e-04 | 10 | 65 | 2 | GO:0004935 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.45e-04 | 49 | 65 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 6.87e-04 | 53 | 65 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 9.26e-04 | 14 | 65 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.22e-03 | 16 | 65 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.37e-03 | 17 | 65 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.37e-03 | 17 | 65 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.72e-03 | 19 | 65 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.72e-03 | 19 | 65 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.34e-03 | 171 | 65 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.51e-03 | 83 | 65 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.53e-03 | 23 | 65 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 3.22e-03 | 26 | 65 | 2 | GO:0050780 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.22e-03 | 26 | 65 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 3.47e-03 | 27 | 65 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 3.73e-03 | 28 | 65 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.73e-03 | 28 | 65 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.75e-03 | 459 | 65 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 4.00e-03 | 29 | 65 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.41e-03 | 109 | 65 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 5.71e-03 | 664 | 65 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.89e-03 | 119 | 65 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | channel activity | 7.15e-03 | 525 | 65 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.21e-03 | 526 | 65 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.89e-03 | 125 | 65 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 8.65e-03 | 43 | 65 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.03e-02 | 138 | 65 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.14e-02 | 758 | 65 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.20e-02 | 51 | 65 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 1.25e-02 | 52 | 65 | 2 | GO:0035255 | |
| GeneOntologyMolecularFunction | symporter activity | 1.29e-02 | 150 | 65 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.61e-02 | 627 | 65 | 6 | GO:0022890 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR4M2 TAS2R4 TAS2R9 DRD1 DRD2 OR5AC1 DRD5 ADRB2 ADRB3 OR2AT4 TAS2R33 OR4A16 OR5L1 GLRA2 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 OR1F2P TACR2 OR8U3 CALCRL OR2T10 LMBRD2 OR5M8 OR13C7 OR8B2 OR8D4 GRM6 OR5AR1 CHRM4 GRPR ADCY6 OR51B2 OR4M2B OR8B3 OR4D2 | 5.28e-28 | 1395 | 65 | 38 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR4M2 TAS2R4 TAS2R9 DRD2 OR5AC1 OR2AT4 TAS2R33 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 1.29e-21 | 547 | 65 | 24 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4M2 TAS2R4 TAS2R9 OR5AC1 OR2AT4 TAS2R33 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 1.89e-21 | 485 | 65 | 23 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4M2 TAS2R4 TAS2R9 OR5AC1 OR2AT4 TAS2R33 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 GRM6 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 5.49e-21 | 582 | 65 | 24 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4M2 TAS2R4 TAS2R9 OR5AC1 OR2AT4 TAS2R33 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 1.08e-20 | 524 | 65 | 23 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR4M2 DRD2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 4.03e-19 | 465 | 65 | 21 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4M2 TAS2R4 TAS2R9 OR5AC1 OR2AT4 TAS2R33 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 GRM6 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 8.08e-19 | 722 | 65 | 24 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 2.03e-18 | 432 | 65 | 20 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception | OR4M2 TAS2R4 TAS2R9 DRD2 OR5AC1 OR2AT4 TAS2R33 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR13C7 OR8B2 OR8D4 GRM6 OR5AR1 OR51B2 OR4M2B OR8B3 OR4D2 | 5.28e-16 | 1072 | 65 | 25 | GO:0007600 |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 1.17e-09 | 35 | 65 | 6 | GO:0071875 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | OR4M2 DRD1 DRD2 DRD5 ADRB2 ADRB3 OR4M1 CALCRL GRM6 CHRM4 ADCY6 | 1.39e-09 | 286 | 65 | 11 | GO:0007188 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A1 SLC6A2 LRRC8E LRRC8C GPR89B SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 GLRA2 AGTR1 NPSR1 GPR89A SLC36A3 TACR2 ATP13A3 CALCRL GRM6 KCNH5 | 4.05e-09 | 1374 | 65 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A1 SLC6A2 LRRC8E LRRC8C GPR89B SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 GLRA2 AGTR1 NPSR1 GPR89A SLC36A3 ATP13A3 GRM6 KCNH5 | 6.01e-09 | 1115 | 65 | 18 | GO:0034220 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 8.47e-09 | 191 | 65 | 9 | GO:0007189 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 1.34e-08 | 25 | 65 | 5 | GO:0071880 | |
| GeneOntologyBiologicalProcess | import into cell | SLC6A1 SLC6A2 LRRC8E LRRC8C SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 ADRB3 ABCA13 AGTR1 CALCRL ATP9A GRM6 LMBRD1 | 1.52e-07 | 1074 | 65 | 16 | GO:0098657 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 6.18e-07 | 230 | 65 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 1.17e-06 | 59 | 65 | 5 | GO:0045761 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.22e-06 | 109 | 65 | 6 | GO:1904427 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 1.65e-06 | 8 | 65 | 3 | GO:0001993 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating dopamine receptor signaling pathway | 2.48e-06 | 9 | 65 | 3 | GO:0060158 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 2.56e-06 | 69 | 65 | 5 | GO:0031279 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 3.38e-06 | 73 | 65 | 5 | GO:0051339 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 3.38e-06 | 73 | 65 | 5 | GO:0071869 | |
| GeneOntologyBiologicalProcess | response to monoamine | 3.62e-06 | 74 | 65 | 5 | GO:0071867 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 3.88e-06 | 34 | 65 | 4 | GO:0007190 | |
| GeneOntologyBiologicalProcess | synaptic transmission, dopaminergic | 4.37e-06 | 35 | 65 | 4 | GO:0001963 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 5.54e-06 | 218 | 65 | 7 | GO:1903169 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 5.66e-06 | 142 | 65 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 5.66e-06 | 142 | 65 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 6.12e-06 | 38 | 65 | 4 | GO:0098810 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A1 SLC6A2 SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 AGTR1 NPSR1 SLC36A3 ATP13A3 GRM6 KCNH5 | 6.25e-06 | 942 | 65 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 7.54e-06 | 40 | 65 | 4 | GO:0045762 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import across plasma membrane | 8.35e-06 | 13 | 65 | 3 | GO:1905665 | |
| GeneOntologyBiologicalProcess | regulation of excretion | 8.35e-06 | 13 | 65 | 3 | GO:0044062 | |
| GeneOntologyBiologicalProcess | dopamine uptake involved in synaptic transmission | 8.35e-06 | 13 | 65 | 3 | GO:0051583 | |
| GeneOntologyBiologicalProcess | catecholamine uptake involved in synaptic transmission | 8.35e-06 | 13 | 65 | 3 | GO:0051934 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.69e-06 | 153 | 65 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 9.02e-06 | 154 | 65 | 6 | GO:0051928 | |
| GeneOntologyBiologicalProcess | G protein-coupled dopamine receptor signaling pathway | 1.11e-05 | 44 | 65 | 4 | GO:0007212 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A1 SLC6A2 SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 AGTR1 NPSR1 SLC36A3 ATP13A3 CALCRL GRM6 KCNH5 | 1.17e-05 | 1157 | 65 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 1.22e-05 | 344 | 65 | 8 | GO:0003018 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A1 SLC6A2 SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 GLRA2 AGTR1 NPSR1 SLC36A3 GRM6 KCNH5 | 1.42e-05 | 1017 | 65 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 1.57e-05 | 48 | 65 | 4 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 1.71e-05 | 49 | 65 | 4 | GO:0051349 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 1.81e-05 | 174 | 65 | 6 | GO:1904064 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 2.02e-05 | 266 | 65 | 7 | GO:0043270 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 2.17e-05 | 52 | 65 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium-dependent cell motility | 2.36e-05 | 18 | 65 | 3 | GO:2000155 | |
| GeneOntologyBiologicalProcess | positive regulation of flagellated sperm motility | 2.36e-05 | 18 | 65 | 3 | GO:1902093 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.40e-05 | 183 | 65 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A1 SLC6A2 SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 AGTR1 NPSR1 SLC36A3 GRM6 KCNH5 | 2.68e-05 | 922 | 65 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | chemical homeostasis | GPR89B OR4M2 SLC9A4 SLC9A1 DRD1 DRD2 DRD5 ABCA12 AGTR1 NPSR1 OR4M1 GPR89A ATP13A3 ADCY6 | 2.75e-05 | 1249 | 65 | 14 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of calcium ion import across plasma membrane | 2.79e-05 | 19 | 65 | 3 | GO:1905664 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium movement | 2.79e-05 | 19 | 65 | 3 | GO:0003353 | |
| GeneOntologyBiologicalProcess | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | 2.93e-05 | 3 | 65 | 2 | GO:0002025 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 3.15e-05 | 192 | 65 | 6 | GO:0034767 | |
| GeneOntologyBiologicalProcess | dopamine uptake | 3.28e-05 | 20 | 65 | 3 | GO:0090494 | |
| GeneOntologyBiologicalProcess | catecholamine uptake | 3.81e-05 | 21 | 65 | 3 | GO:0090493 | |
| GeneOntologyBiologicalProcess | regulation of pH | 3.83e-05 | 120 | 65 | 5 | GO:0006885 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 4.10e-05 | 61 | 65 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 4.10e-05 | 61 | 65 | 4 | GO:0003044 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 4.18e-05 | 202 | 65 | 6 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 4.18e-05 | 202 | 65 | 6 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 4.30e-05 | 203 | 65 | 6 | GO:0035150 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 4.48e-05 | 124 | 65 | 5 | GO:0003073 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC6A2 LRRC8E GPR89B SLC9A4 SLC9A1 DRD1 DRD2 DRD5 ABCA12 NPSR1 GPR89A ATP13A3 | 4.90e-05 | 981 | 65 | 12 | GO:0019725 |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 4.95e-05 | 64 | 65 | 4 | GO:1903351 | |
| GeneOntologyBiologicalProcess | learning | 5.47e-05 | 212 | 65 | 6 | GO:0007612 | |
| GeneOntologyBiologicalProcess | response to dopamine | 5.59e-05 | 66 | 65 | 4 | GO:1903350 | |
| GeneOntologyBiologicalProcess | associative learning | 5.62e-05 | 130 | 65 | 5 | GO:0008306 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A1 SLC6A2 SLC9A4 SLC9A1 DRD1 DRD2 ADRB2 AGTR1 NPSR1 CALCRL GRM6 KCNH5 | 5.89e-05 | 1000 | 65 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 6.23e-05 | 217 | 65 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 6.26e-05 | 133 | 65 | 5 | GO:0007200 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 6.26e-05 | 133 | 65 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 6.29e-05 | 68 | 65 | 4 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 6.29e-05 | 68 | 65 | 4 | GO:0071870 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | GPR89B SLC9A4 SLC9A1 DRD1 DRD2 DRD5 AGTR1 NPSR1 GPR89A ATP13A3 | 6.69e-05 | 705 | 65 | 10 | GO:0055080 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 6.92e-05 | 323 | 65 | 7 | GO:0051924 | |
| GeneOntologyBiologicalProcess | negative regulation of blood pressure | 7.04e-05 | 70 | 65 | 4 | GO:0045776 | |
| GeneOntologyBiologicalProcess | response to cocaine | 7.45e-05 | 71 | 65 | 4 | GO:0042220 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | GPR89B SLC9A4 SLC9A1 DRD1 DRD2 DRD5 AGTR1 NPSR1 GPR89A ATP13A3 | 7.69e-05 | 717 | 65 | 10 | GO:0050801 |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 8.28e-05 | 27 | 65 | 3 | GO:0098719 | |
| GeneOntologyBiologicalProcess | circulatory system process | 9.23e-05 | 733 | 65 | 10 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of flagellated sperm motility | 9.25e-05 | 28 | 65 | 3 | GO:1901317 | |
| GeneOntologyBiologicalProcess | behavior | SLC6A1 DRD1 DRD2 DRD5 ADRB2 ADRB3 AGTR1 NPSR1 TACR2 GRM6 GRPR | 9.70e-05 | 891 | 65 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | operant conditioning | 9.72e-05 | 5 | 65 | 2 | GO:0035106 | |
| GeneOntologyBiologicalProcess | sensitization | 9.72e-05 | 5 | 65 | 2 | GO:0046960 | |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 1.14e-04 | 30 | 65 | 3 | GO:0014821 | |
| GeneOntologyBiologicalProcess | regulation of urine volume | 1.14e-04 | 30 | 65 | 3 | GO:0035809 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 1.19e-04 | 80 | 65 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 1.21e-04 | 611 | 65 | 9 | GO:0030003 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.38e-04 | 622 | 65 | 9 | GO:0006873 | |
| GeneOntologyBiologicalProcess | negative regulation of circadian sleep/wake cycle, sleep | 1.45e-04 | 6 | 65 | 2 | GO:0042321 | |
| GeneOntologyBiologicalProcess | cerebral cortex GABAergic interneuron migration | 1.45e-04 | 6 | 65 | 2 | GO:0021853 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.57e-04 | 86 | 65 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.59e-04 | 162 | 65 | 5 | GO:0007631 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import | 1.67e-04 | 34 | 65 | 3 | GO:0090280 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.69e-04 | 373 | 65 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.87e-04 | 648 | 65 | 9 | GO:0008015 | |
| GeneOntologyCellularComponent | G protein-coupled receptor complex | 4.87e-06 | 11 | 66 | 3 | GO:0097648 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.99e-05 | 405 | 66 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | synaptic membrane | 8.62e-05 | 583 | 66 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | ciliary membrane | 2.62e-04 | 98 | 66 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.22e-03 | 378 | 66 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.28e-03 | 523 | 66 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.71e-03 | 550 | 66 | 7 | GO:1990351 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.80e-03 | 164 | 66 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.82e-03 | 277 | 66 | 5 | GO:0042734 | |
| MousePheno | abnormal behavioral response to addictive substance | 7.77e-06 | 102 | 38 | 5 | MP:0009748 | |
| MousePheno | abnormal synaptic physiology | SLC6A1 SLC6A2 SLC9A4 VRK2 DRD1 DRD2 ABCA13 GLRA2 LBR ATP9A GRM6 CHRM4 | 1.68e-05 | 1076 | 38 | 12 | MP:0021009 |
| MousePheno | decreased response to stress-induced hyperthermia | 7.16e-05 | 5 | 38 | 2 | MP:0010167 | |
| MousePheno | abnormal consumption behavior | 7.83e-05 | 695 | 38 | 9 | MP:0002069 | |
| MousePheno | abnormal latent inhibition of conditioning behavior | 1.07e-04 | 6 | 38 | 2 | MP:0006299 | |
| MousePheno | decreased hepatic glucose production | 1.50e-04 | 7 | 38 | 2 | MP:0020103 | |
| MousePheno | abnormal behavioral response to xenobiotic | 1.69e-04 | 309 | 38 | 6 | MP:0009745 | |
| MousePheno | increased fluid intake | 1.76e-04 | 104 | 38 | 4 | MP:0011941 | |
| MousePheno | behavioral despair | 2.27e-04 | 44 | 38 | 3 | MP:0002573 | |
| MousePheno | impaired behavioral response to addictive substance | 2.43e-04 | 45 | 38 | 3 | MP:0009750 | |
| MousePheno | abnormal synaptic transmission | 4.32e-04 | 1070 | 38 | 10 | MP:0003635 | |
| MousePheno | abnormal response to stress-induced hyperthermia | 4.67e-04 | 12 | 38 | 2 | MP:0010165 | |
| MousePheno | abnormal fluid intake | 4.89e-04 | 136 | 38 | 4 | MP:0011947 | |
| MousePheno | abnormal operant conditioning behavior | 5.51e-04 | 13 | 38 | 2 | MP:0002803 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR4M2 TAS2R9 DRD1 DRD2 DRD5 ADRB2 ADRB3 OR2AT4 OR4A16 OR5L1 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 OR1F2P TACR2 OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 CHRM4 GRPR OR51B2 OR8B3 OR4D2 | 8.90e-25 | 691 | 59 | 28 | PS50262 |
| Domain | GPCR_Rhodpsn | OR4M2 TAS2R9 DRD1 DRD2 DRD5 ADRB2 ADRB3 OR2AT4 OR4A16 OR5L1 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 OR1F2P TACR2 OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 CHRM4 GRPR OR51B2 OR8B3 OR4D2 | 9.26e-25 | 692 | 59 | 28 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR4M2 TAS2R9 DRD1 DRD2 DRD5 ADRB2 ADRB3 OR2AT4 OR4A16 OR5L1 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 TACR2 OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 CHRM4 GRPR OR51B2 OR8B3 OR4D2 | 9.36e-24 | 670 | 59 | 27 | IPR017452 |
| Domain | 7tm_1 | OR4M2 DRD1 DRD2 DRD5 ADRB2 ADRB3 OR2AT4 OR4A16 OR5L1 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 OR1F2P TACR2 OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 CHRM4 GRPR OR51B2 OR8B3 OR4D2 | 1.23e-23 | 677 | 59 | 27 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR4M2 DRD1 DRD2 DRD5 ADRB2 ADRB3 OR2AT4 OR4A16 OR5L1 AGTR1 NPSR1 OR5B17 OR2G2 OR4M1 OR1F2P TACR2 OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 CHRM4 GRPR OR51B2 OR8B3 OR4D2 | 1.68e-23 | 685 | 59 | 27 | PS00237 |
| Domain | Olfact_rcpt | OR4M2 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 OR51B2 OR8B3 OR4D2 | 2.73e-15 | 393 | 59 | 17 | IPR000725 |
| Domain | 7TM_GPCR_Srsx | 7.08e-11 | 112 | 59 | 9 | SM01381 | |
| Domain | Dopamine_rcpt | 2.98e-07 | 5 | 59 | 3 | IPR000929 | |
| Domain | NEXCaM_BD | 2.94e-05 | 3 | 59 | 2 | PF16644 | |
| Domain | NHE_CaM-bd | 2.94e-05 | 3 | 59 | 2 | IPR032103 | |
| Domain | LMBR1 | 5.86e-05 | 4 | 59 | 2 | PF04791 | |
| Domain | LMBR1-like_membr_prot | 5.86e-05 | 4 | 59 | 2 | IPR006876 | |
| Domain | LRRC8_Pannexin-like | 9.75e-05 | 5 | 59 | 2 | IPR021040 | |
| Domain | Pannexin_like | 9.75e-05 | 5 | 59 | 2 | PF12534 | |
| Domain | NaH_exchanger | 3.48e-04 | 9 | 59 | 2 | IPR004709 | |
| Domain | ADR_fam | 4.34e-04 | 10 | 59 | 2 | IPR002233 | |
| Domain | Cation/H_exchanger_CPA1 | 5.30e-04 | 11 | 59 | 2 | IPR018422 | |
| Domain | ABC_A | 6.34e-04 | 12 | 59 | 2 | IPR026082 | |
| Domain | Na_H_Exchanger | 8.71e-04 | 14 | 59 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 8.71e-04 | 14 | 59 | 2 | IPR006153 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.45e-03 | 18 | 59 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.62e-03 | 19 | 59 | 2 | PS50267 | |
| Domain | SNF | 1.62e-03 | 19 | 59 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 1.62e-03 | 19 | 59 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.62e-03 | 19 | 59 | 2 | PS00610 | |
| Domain | TAS2R | 3.04e-03 | 26 | 59 | 2 | PF05296 | |
| Domain | T2R | 3.04e-03 | 26 | 59 | 2 | IPR007960 | |
| Domain | - | 4.58e-03 | 32 | 59 | 2 | 2.70.150.10 | |
| Domain | - | 4.58e-03 | 32 | 59 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 5.46e-03 | 35 | 59 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.77e-03 | 36 | 59 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 5.77e-03 | 36 | 59 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.77e-03 | 36 | 59 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.09e-03 | 37 | 59 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.09e-03 | 37 | 59 | 2 | PF00122 | |
| Domain | ABC_TRANSPORTER_2 | 1.01e-02 | 48 | 59 | 2 | PS50893 | |
| Domain | ABC_tran | 1.01e-02 | 48 | 59 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 1.05e-02 | 49 | 59 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 1.09e-02 | 50 | 59 | 2 | IPR003439 | |
| Domain | - | 1.74e-02 | 64 | 59 | 2 | 3.40.50.1000 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 OR51B2 OR8B3 OR4D2 | 1.79e-13 | 417 | 55 | 17 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR4M2 TAS2R4 OR5AC1 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 OR51B2 OR8B3 OR4D2 | 1.43e-11 | 636 | 55 | 18 | M41834 |
| Pathway | WP_GPCRS_NONODORANT | TAS2R4 DRD1 DRD2 DRD5 ADRB2 ADRB3 AGTR1 NPSR1 TACR2 CALCRL GRM6 CHRM4 GRPR | 2.06e-11 | 266 | 55 | 13 | MM15843 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR4M2 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR8U3 OR2T10 OR5M8 OR8D4 OR5AR1 OR51B2 OR4D2 | 1.83e-10 | 389 | 55 | 14 | M14091 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | DRD1 DRD2 DRD5 ADRB2 ADRB3 GLRA2 AGTR1 TACR2 CALCRL GRM6 CHRM4 GRPR | 4.39e-10 | 272 | 55 | 12 | M13380 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | TAS2R4 TAS2R9 DRD1 DRD2 DRD5 ADRB2 ADRB3 AGTR1 NPSR1 TACR2 CALCRL GRM6 CHRM4 GRPR | 1.77e-09 | 463 | 55 | 14 | M507 |
| Pathway | WP_MONOAMINE_GPCRS | 1.82e-09 | 31 | 55 | 6 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 2.72e-09 | 33 | 55 | 6 | M39585 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | TAS2R4 DRD1 DRD2 DRD5 ADRB2 ADRB3 AGTR1 NPSR1 TACR2 CALCRL GRM6 CHRM4 GRPR | 7.47e-09 | 430 | 55 | 13 | MM15160 |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.25e-08 | 42 | 55 | 6 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.25e-08 | 42 | 55 | 6 | MM14971 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | TAS2R4 TAS2R9 DRD1 DRD2 DRD5 ADRB2 ADRB3 AGTR1 NPSR1 TACR2 CALCRL GRM6 CHRM4 GRPR ADCY6 | 4.58e-08 | 702 | 55 | 15 | M746 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | TAS2R4 DRD1 DRD2 DRD5 ADRB2 ADRB3 AGTR1 NPSR1 TACR2 CALCRL GRM6 CHRM4 GRPR ADCY6 | 1.19e-07 | 646 | 55 | 14 | MM14962 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.95e-07 | 330 | 55 | 10 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 5.38e-07 | 333 | 55 | 10 | MM14963 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 5.59e-07 | 5 | 55 | 3 | M27301 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 5.59e-07 | 5 | 55 | 3 | MM15007 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.41e-06 | 157 | 55 | 7 | M4904 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.54e-06 | 178 | 55 | 7 | M2890 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 6.92e-06 | 260 | 55 | 8 | M39397 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.89e-05 | 143 | 55 | 6 | MM15055 | |
| Pathway | WP_GPCRS_OTHER | 3.50e-05 | 96 | 55 | 5 | MM15939 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 8.17e-05 | 367 | 55 | 8 | M48346 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 8.25e-05 | 186 | 55 | 6 | MM15994 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.57e-04 | 70 | 55 | 4 | MM14984 | |
| Pathway | WP_GPCRS_ODORANT | 3.57e-04 | 157 | 55 | 5 | MM15872 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 4.65e-04 | 39 | 55 | 3 | M793 | |
| Pathway | REACTOME_ADRENOCEPTORS | 5.29e-04 | 9 | 55 | 2 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 5.29e-04 | 9 | 55 | 2 | MM15009 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 5.29e-04 | 9 | 55 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 5.29e-04 | 9 | 55 | 2 | MM15079 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 8.50e-04 | 190 | 55 | 5 | MM15687 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 9.67e-04 | 50 | 55 | 3 | M47951 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 1.08e-03 | 52 | 55 | 3 | M5785 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.28e-03 | 55 | 55 | 3 | M39763 | |
| Pathway | BIOCARTA_CK1_PATHWAY | 1.52e-03 | 15 | 55 | 2 | MM1468 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.52e-03 | 15 | 55 | 2 | M47794 | |
| Pathway | BIOCARTA_CK1_PATHWAY | 1.73e-03 | 16 | 55 | 2 | M16626 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 1.73e-03 | 16 | 55 | 2 | M39849 | |
| Pathway | REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION | 1.96e-03 | 17 | 55 | 2 | MM14920 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A1 SLC6A2 LRRC8E LRRC8C SLC9A4 SLC9A1 ABCA12 ATP9A ADCY6 | 2.01e-03 | 736 | 55 | 9 | M27287 |
| Pathway | WP_GPCRS_ORPHAN | 2.45e-03 | 19 | 55 | 2 | MM15991 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.45e-03 | 19 | 55 | 2 | MM15107 | |
| Pathway | REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION | 2.45e-03 | 19 | 55 | 2 | M29617 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.45e-03 | 19 | 55 | 2 | M27362 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.56e-03 | 70 | 55 | 3 | MM15959 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.56e-03 | 147 | 55 | 4 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.82e-03 | 151 | 55 | 4 | M39329 | |
| Pathway | WP_PEPTIDE_GPCRS | 3.11e-03 | 75 | 55 | 3 | M39696 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 4.23e-03 | 25 | 55 | 2 | MM15172 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 4.57e-03 | 26 | 55 | 2 | M27424 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 4.64e-03 | 681 | 55 | 8 | MM14985 | |
| Pathway | KEGG_GAP_JUNCTION | 5.20e-03 | 90 | 55 | 3 | M4013 | |
| Pathway | WP_MONOAMINE_TRANSPORT | 6.88e-03 | 32 | 55 | 2 | M39724 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.24e-03 | 197 | 55 | 4 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.24e-03 | 197 | 55 | 4 | MM14970 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR4M1 OR1F2P OR8U3 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR8B3 OR4D2 | 2.69e-18 | 340 | 66 | 16 | 11875048 |
| Pubmed | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR4M1 OR1F2P OR8U3 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR8B3 OR4D2 | 2.69e-18 | 340 | 66 | 16 | 11802173 | |
| Pubmed | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR4M1 OR1F2P OR8U3 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR8B3 OR4D2 | 3.09e-18 | 343 | 66 | 16 | 32295537 | |
| Pubmed | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR4M1 OR1F2P OR8U3 OR5M8 OR13C7 OR8B2 OR8D4 OR5AR1 OR51B2 OR8B3 OR4D2 | 3.55e-18 | 346 | 66 | 16 | 14611657 | |
| Pubmed | OR4M2 OR5AC1 OR2AT4 OR4A16 OR5L1 OR5B17 OR2G2 OR4M1 OR1F2P OR8U3 OR2T10 OR5M8 OR8B2 OR8D4 OR5AR1 OR8B3 OR4D2 | 1.77e-16 | 541 | 66 | 17 | 14983052 | |
| Pubmed | 1.60e-10 | 200 | 66 | 9 | 18240029 | ||
| Pubmed | 2.70e-10 | 300 | 66 | 10 | 19086053 | ||
| Pubmed | 4.41e-09 | 70 | 66 | 6 | 12036966 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 5.61e-09 | 130 | 66 | 7 | 19874574 | |
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 19171671 | ||
| Pubmed | Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. | 6.53e-09 | 3 | 66 | 3 | 18172057 | |
| Pubmed | Aging-related dysregulation of dopamine and angiotensin receptor interaction. | 6.53e-09 | 3 | 66 | 3 | 24529758 | |
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 12867509 | ||
| Pubmed | 1.01e-08 | 38 | 66 | 5 | 22908908 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 16962565 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 12967601 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 29541380 | ||
| Pubmed | Dopamine genes and pathological gambling in discordant sib-pairs. | 2.61e-08 | 4 | 66 | 3 | 17394052 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 25049074 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 18403039 | ||
| Pubmed | 5.12e-08 | 52 | 66 | 5 | 8288218 | ||
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 9457173 | ||
| Pubmed | [Dopamine receptor signaling regulates human osteoclastogenesis]. | 6.51e-08 | 5 | 66 | 3 | 23445730 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 25560761 | ||
| Pubmed | Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes. | 6.51e-08 | 5 | 66 | 3 | 22219295 | |
| Pubmed | Redundant catecholamine signaling consolidates fear memory via phospholipase C. | 6.51e-08 | 5 | 66 | 3 | 22323706 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 26597879 | ||
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 19105202 | ||
| Pubmed | Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. | 6.51e-08 | 5 | 66 | 3 | 12509874 | |
| Pubmed | Dopamine receptor loss of function is not protective of rd1 rod photoreceptors in vivo. | 6.51e-08 | 5 | 66 | 3 | 20038975 | |
| Pubmed | Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain. | 6.51e-08 | 5 | 66 | 3 | 20714340 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 23753418 | ||
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 17509542 | ||
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 18083900 | ||
| Pubmed | 6.91e-08 | 21 | 66 | 4 | 15452121 | ||
| Pubmed | Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. | 1.30e-07 | 6 | 66 | 3 | 21982372 | |
| Pubmed | DISC1 regulates primary cilia that display specific dopamine receptors. | 1.30e-07 | 6 | 66 | 3 | 20531939 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.67e-07 | 128 | 66 | 6 | 19058789 | |
| Pubmed | Two-stage case-control association study of dopamine-related genes and migraine. | 5.44e-07 | 9 | 66 | 3 | 19772578 | |
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 16525059 | ||
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 12297500 | ||
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 18821566 | ||
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 12777963 | ||
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 5.92e-07 | 35 | 66 | 4 | 16939646 | |
| Pubmed | 7.76e-07 | 10 | 66 | 3 | 21083670 | ||
| Pubmed | Support for association between ADHD and two candidate genes: NET1 and DRD1. | 1.07e-06 | 11 | 66 | 3 | 15717291 | |
| Pubmed | 1.07e-06 | 11 | 66 | 3 | 19779464 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 1.32e-06 | 182 | 66 | 6 | 20468064 | |
| Pubmed | 1.98e-06 | 47 | 66 | 4 | 18821565 | ||
| Pubmed | 2.76e-06 | 51 | 66 | 4 | 20351714 | ||
| Pubmed | 2.92e-06 | 15 | 66 | 3 | 26053317 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 3.13e-06 | 118 | 66 | 5 | 19156168 | |
| Pubmed | Lack of dopaminergic inputs elongates the primary cilia of striatal neurons. | 3.55e-06 | 2 | 66 | 2 | 24830745 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26442961 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19228458 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 36464669 | ||
| Pubmed | Early maternal separation accelerates the progression of endometriosis in adult mice. | 3.55e-06 | 2 | 66 | 2 | 32532293 | |
| Pubmed | Polymorphisms in dopaminergic genes predict proactive processes of response inhibition. | 3.55e-06 | 2 | 66 | 2 | 30586202 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 14960355 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 8294904 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 9988094 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 21893192 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 32833186 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26763483 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26888112 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 21303698 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 11567069 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12417685 | ||
| Pubmed | When chocolate seeking becomes compulsion: gene-environment interplay. | 3.55e-06 | 2 | 66 | 2 | 25781028 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16449022 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 8001143 | ||
| Pubmed | Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. | 3.55e-06 | 2 | 66 | 2 | 17324452 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 24078558 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 24322206 | ||
| Pubmed | Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor. | 3.55e-06 | 2 | 66 | 2 | 28119185 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19117916 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26174222 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 22100647 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 11706779 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16009000 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16846218 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 20081237 | ||
| Pubmed | Distinct functions of the two isoforms of dopamine D2 receptors. | 3.55e-06 | 2 | 66 | 2 | 11089973 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12629568 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28473642 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28860974 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17409246 | ||
| Pubmed | PV plasticity sustained through D1/5 dopamine signaling required for long-term memory consolidation. | 3.55e-06 | 2 | 66 | 2 | 26807952 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16027735 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 20138019 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 18363855 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 33380525 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12824951 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 20592018 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 29183706 | ||
| Pubmed | Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice. | 3.55e-06 | 2 | 66 | 2 | 17712281 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 18030347 | ||
| Pubmed | D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms. | 3.55e-06 | 2 | 66 | 2 | 23680635 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27021648 | ||
| Pubmed | Localization of peripheral dopamine D1 and D2 receptors in rat and human seminal vesicles. | 3.55e-06 | 2 | 66 | 2 | 11783439 | |
| Interaction | CCR6 interactions | 8.50e-08 | 89 | 50 | 6 | int:CCR6 | |
| Interaction | FPR2 interactions | 1.15e-06 | 138 | 50 | 6 | int:FPR2 | |
| Interaction | TSPAN15 interactions | 5.06e-06 | 276 | 50 | 7 | int:TSPAN15 | |
| Interaction | YIPF3 interactions | 6.47e-06 | 186 | 50 | 6 | int:YIPF3 | |
| Interaction | DNAJC14 interactions | 7.10e-06 | 50 | 50 | 4 | int:DNAJC14 | |
| Interaction | TTYH1 interactions | 8.72e-06 | 300 | 50 | 7 | int:TTYH1 | |
| Interaction | LPAR1 interactions | 1.29e-05 | 210 | 50 | 6 | int:LPAR1 | |
| Interaction | LRRC55 interactions | 2.16e-05 | 66 | 50 | 4 | int:LRRC55 | |
| Interaction | GPRASP1 interactions | 2.29e-05 | 67 | 50 | 4 | int:GPRASP1 | |
| Interaction | OR10H2 interactions | 3.05e-05 | 72 | 50 | 4 | int:OR10H2 | |
| Interaction | SLC39A4 interactions | 5.14e-05 | 163 | 50 | 5 | int:SLC39A4 | |
| Interaction | HRH3 interactions | 6.00e-05 | 5 | 50 | 2 | int:HRH3 | |
| Interaction | TMEM101 interactions | 6.15e-05 | 31 | 50 | 3 | int:TMEM101 | |
| Interaction | TSPAN7 interactions | 6.77e-05 | 32 | 50 | 3 | int:TSPAN7 | |
| Interaction | LGALS8 interactions | 7.01e-05 | 174 | 50 | 5 | int:LGALS8 | |
| Interaction | ADRB3 interactions | 8.99e-05 | 6 | 50 | 2 | int:ADRB3 | |
| Interaction | C3orf52 interactions | 1.04e-04 | 305 | 50 | 6 | int:C3orf52 | |
| Interaction | SMIM7 interactions | 1.26e-04 | 7 | 50 | 2 | int:SMIM7 | |
| Interaction | NIPAL1 interactions | 1.83e-04 | 114 | 50 | 4 | int:NIPAL1 | |
| Interaction | IPPK interactions | 1.96e-04 | 116 | 50 | 4 | int:IPPK | |
| Interaction | CYP19A1 interactions | 2.02e-04 | 46 | 50 | 3 | int:CYP19A1 | |
| Interaction | KCNJ9 interactions | 2.15e-04 | 9 | 50 | 2 | int:KCNJ9 | |
| Interaction | KCNA2 interactions | 2.61e-04 | 125 | 50 | 4 | int:KCNA2 | |
| Interaction | PTGER1 interactions | 2.68e-04 | 10 | 50 | 2 | int:PTGER1 | |
| Interaction | ICAM2 interactions | 4.03e-04 | 58 | 50 | 3 | int:ICAM2 | |
| Interaction | GRPR interactions | 4.67e-04 | 61 | 50 | 3 | int:GRPR | |
| Interaction | CHP2 interactions | 5.39e-04 | 14 | 50 | 2 | int:CHP2 | |
| Interaction | JKAMP interactions | 5.39e-04 | 14 | 50 | 2 | int:JKAMP | |
| Interaction | NKAIN1 interactions | 5.63e-04 | 65 | 50 | 3 | int:NKAIN1 | |
| Interaction | CRELD1 interactions | 7.11e-04 | 163 | 50 | 4 | int:CRELD1 | |
| Interaction | CHRNB4 interactions | 7.60e-04 | 72 | 50 | 3 | int:CHRNB4 | |
| Interaction | GPR182 interactions | 8.78e-04 | 455 | 50 | 6 | int:GPR182 | |
| Interaction | TACR3 interactions | 8.89e-04 | 76 | 50 | 3 | int:TACR3 | |
| Interaction | RAB4A interactions | 8.98e-04 | 457 | 50 | 6 | int:RAB4A | |
| Interaction | KCNJ3 interactions | 9.00e-04 | 18 | 50 | 2 | int:KCNJ3 | |
| Interaction | STRA6 interactions | 9.00e-04 | 18 | 50 | 2 | int:STRA6 | |
| Interaction | TCTN2 interactions | 9.19e-04 | 304 | 50 | 5 | int:TCTN2 | |
| Interaction | SLC1A1 interactions | 9.67e-04 | 177 | 50 | 4 | int:SLC1A1 | |
| Interaction | ADCK1 interactions | 9.95e-04 | 79 | 50 | 3 | int:ADCK1 | |
| Interaction | RAB3B interactions | 1.00e-03 | 310 | 50 | 5 | int:RAB3B | |
| Interaction | SERINC3 interactions | 1.00e-03 | 19 | 50 | 2 | int:SERINC3 | |
| Interaction | GPR37 interactions | 1.07e-03 | 81 | 50 | 3 | int:GPR37 | |
| Interaction | MBOAT7 interactions | 1.07e-03 | 182 | 50 | 4 | int:MBOAT7 | |
| Cytoband | 11q12.1 | 8.35e-05 | 161 | 65 | 4 | 11q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.33e-04 | 345 | 65 | 5 | chr11q12 | |
| Cytoband | 11q24.1 | 1.27e-03 | 37 | 65 | 2 | 11q24.1 | |
| Cytoband | Xp22.2 | 1.49e-03 | 40 | 65 | 2 | Xp22.2 | |
| Cytoband | 11q11 | 2.05e-03 | 47 | 65 | 2 | 11q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 2.56e-03 | 191 | 65 | 3 | chr11q24 | |
| Cytoband | 1q21.1 | 3.53e-03 | 62 | 65 | 2 | 1q21.1 | |
| GeneFamily | Dopamine receptors | 2.80e-07 | 5 | 56 | 3 | 181 | |
| GeneFamily | Olfactory receptors, family 5 | 1.25e-06 | 112 | 56 | 6 | 152 | |
| GeneFamily | Volume regulated anion channel subunits | 9.37e-05 | 5 | 56 | 2 | 1158 | |
| GeneFamily | Taste 2 receptors | 2.38e-04 | 39 | 56 | 3 | 1162 | |
| GeneFamily | Adrenoceptors | 3.35e-04 | 9 | 56 | 2 | 169 | |
| GeneFamily | Olfactory receptors, family 8 | 4.69e-04 | 49 | 56 | 3 | 155 | |
| GeneFamily | Olfactory receptors, family 4 | 6.82e-04 | 129 | 56 | 4 | 151 | |
| GeneFamily | ATP binding cassette subfamily A | 8.37e-04 | 14 | 56 | 2 | 805 | |
| GeneFamily | Solute carriers | 1.35e-03 | 395 | 56 | 6 | 752 | |
| GeneFamily | Olfactory receptors, family 2 | 5.18e-03 | 113 | 56 | 3 | 149 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | SLC6A2 DRD1 DRD2 ADRB2 ADRB3 OR2AT4 AGTR1 TACR2 CALCRL ATP9A OR13C7 GRPR KCNH5 | 4.23e-06 | 1281 | 59 | 13 | M1884 |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-06 | 136 | 64 | 5 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Whrn_Tox2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.98e-06 | 143 | 64 | 5 | 36ce6f163fb33141c86288086c354b91853fad25 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-06 | 149 | 64 | 5 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-06 | 188 | 64 | 5 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| Computational | Genes in the cancer module 288. | 1.04e-04 | 37 | 27 | 3 | MODULE_288 | |
| Computational | Genes in the cancer module 146. | 1.13e-04 | 102 | 27 | 4 | MODULE_146 | |
| Computational | Membranal receptors. | 2.19e-04 | 517 | 27 | 7 | MODULE_64 | |
| Computational | Genes in the cancer module 162. | 1.01e-03 | 19 | 27 | 2 | MODULE_162 | |
| Computational | Vesicular transport / synapse genes. | 1.10e-03 | 82 | 27 | 3 | MODULE_274 | |
| Computational | Genes in the cancer module 218. | 1.12e-03 | 20 | 27 | 2 | MODULE_218 | |
| Drug | DO 710 | 2.91e-11 | 10 | 61 | 5 | CID003084985 | |
| Drug | 3-isoreserpine | 8.05e-11 | 190 | 61 | 10 | CID000005052 | |
| Drug | Bulbokaprin | 1.48e-10 | 13 | 61 | 5 | CID000009276 | |
| Drug | AC1Q5UBL | 1.87e-10 | 146 | 61 | 9 | CID000005466 | |
| Drug | benzimidazol-2-one | 2.29e-10 | 14 | 61 | 5 | CID000162542 | |
| Drug | dopexamine | 2.47e-10 | 32 | 61 | 6 | CID000055483 | |
| Drug | delta H | 4.99e-10 | 16 | 61 | 5 | CID000034771 | |
| Drug | N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine | 6.58e-10 | 69 | 61 | 7 | CID000003172 | |
| Drug | fenoldopam | 7.30e-10 | 70 | 61 | 7 | CID000003340 | |
| Drug | NSC95090 | 1.03e-09 | 40 | 61 | 6 | CID000003251 | |
| Drug | DAR-0100A | 1.20e-09 | 41 | 61 | 6 | CID000060759 | |
| Drug | nisoxetine | 1.40e-09 | 42 | 61 | 6 | CID000004500 | |
| Drug | phentolamine | 3.04e-09 | 200 | 61 | 9 | CID000005775 | |
| Drug | Neomigran | 3.23e-09 | 48 | 61 | 6 | CID000003066 | |
| Drug | 1-methyl-3,4-dihydroisoquinoline | 3.24e-09 | 8 | 61 | 4 | CID000231502 | |
| Drug | mianserin | 3.43e-09 | 87 | 61 | 7 | CID000004184 | |
| Drug | dihydroergocryptine | 3.67e-09 | 49 | 61 | 6 | CID000114948 | |
| Drug | amitriptyline | 3.74e-09 | 140 | 61 | 8 | CID000002160 | |
| Drug | 5,6-dihydroxy-2-dimethylaminotetralin | 4.77e-09 | 24 | 61 | 5 | CID000037032 | |
| Drug | ibopamine | 4.77e-09 | 24 | 61 | 5 | CID000068555 | |
| Drug | epinine | 4.77e-09 | 24 | 61 | 5 | CID000004382 | |
| Drug | mirtazapine | 6.71e-09 | 54 | 61 | 6 | CID000004205 | |
| Drug | tardan | 7.36e-09 | 26 | 61 | 5 | CID000002729 | |
| Drug | piperoxan | 7.36e-09 | 26 | 61 | 5 | CID000006040 | |
| Drug | MHPG | 9.38e-09 | 57 | 61 | 6 | CID000010805 | |
| Drug | AC1L1CM5 | 1.52e-08 | 11 | 61 | 4 | CID000001961 | |
| Drug | AC1LR3WA | 1.83e-08 | 3 | 61 | 3 | CID001361946 | |
| Drug | carphenazine | 1.83e-08 | 3 | 61 | 3 | CID000018104 | |
| Drug | Carphenazine | 1.83e-08 | 3 | 61 | 3 | DB01038 | |
| Drug | S-(-)-Lisuride | 2.10e-08 | 65 | 61 | 6 | CID000003938 | |
| Drug | talsupram | 2.27e-08 | 12 | 61 | 4 | CID000033013 | |
| Drug | alpha-methyl-p-tyrosine | 2.30e-08 | 66 | 61 | 6 | CID000003125 | |
| Drug | reboxetine | 2.53e-08 | 67 | 61 | 6 | CID000065856 | |
| Drug | NSC186061 | 2.90e-08 | 118 | 61 | 7 | CID000004163 | |
| Drug | desipramine | 3.77e-08 | 188 | 61 | 8 | CID000002995 | |
| Drug | EEDQ | 3.91e-08 | 72 | 61 | 6 | CID000027833 | |
| Drug | azaperone | 4.57e-08 | 14 | 61 | 4 | CID000015443 | |
| Drug | A68930 | 4.57e-08 | 14 | 61 | 4 | CID000122324 | |
| Drug | Rp-cAMPS | 4.81e-08 | 194 | 61 | 8 | CID006426631 | |
| Drug | clorgyline | 5.01e-08 | 75 | 61 | 6 | CID000004380 | |
| Drug | EN-1530 | 5.28e-08 | 278 | 61 | 9 | CID000004425 | |
| Drug | tyramine | 5.68e-08 | 130 | 61 | 7 | CID000005610 | |
| Drug | methiothepin | 5.88e-08 | 77 | 61 | 6 | CID000004106 | |
| Drug | H-8105 | 5.96e-08 | 282 | 61 | 9 | CID000164531 | |
| Drug | SKF 75670 | 6.22e-08 | 15 | 61 | 4 | CID000173870 | |
| Drug | A 86929 | 6.22e-08 | 15 | 61 | 4 | ctd:C095427 | |
| Drug | HV723 | 6.22e-08 | 15 | 61 | 4 | CID003081094 | |
| Drug | AC1L2AAS | 6.22e-08 | 15 | 61 | 4 | CID000068714 | |
| Drug | amphetamine | 6.33e-08 | 284 | 61 | 9 | CID000003007 | |
| Drug | dimethocaine | 7.31e-08 | 4 | 61 | 3 | CID000007177 | |
| Drug | MK-458 | 7.31e-08 | 4 | 61 | 3 | CID000057532 | |
| Drug | DK-118 | 7.31e-08 | 4 | 61 | 3 | CID000145953 | |
| Drug | buspirone | 7.40e-08 | 80 | 61 | 6 | CID000002477 | |
| Drug | spiroxatrine | 9.20e-08 | 42 | 61 | 5 | CID000005268 | |
| Drug | NSD-1015 | 1.04e-07 | 43 | 61 | 5 | CID000001663 | |
| Drug | mecoprop | 1.17e-07 | 44 | 61 | 5 | CID000007153 | |
| Drug | pilocarpine- | 1.32e-07 | 147 | 61 | 7 | CID000004819 | |
| Drug | AMPT | 1.39e-07 | 18 | 61 | 4 | CID000002112 | |
| Drug | idazoxan | 1.41e-07 | 89 | 61 | 6 | CID000054459 | |
| Drug | amoxapine | 1.47e-07 | 46 | 61 | 5 | CID000002170 | |
| Drug | B-HT 920 | 1.64e-07 | 47 | 61 | 5 | CID000005374 | |
| Drug | Ro 41-9067 | 1.75e-07 | 19 | 61 | 4 | CID000125800 | |
| Drug | Methotrimeprazine | 1.75e-07 | 19 | 61 | 4 | DB01403 | |
| Drug | tilozepine | 1.82e-07 | 5 | 61 | 3 | CID000172286 | |
| Drug | 2-di-n-propylaminoindan | 1.82e-07 | 5 | 61 | 3 | CID000130402 | |
| Drug | mezilamine | 1.82e-07 | 5 | 61 | 3 | CID000068678 | |
| Drug | C9H11N3O2 | 1.82e-07 | 5 | 61 | 3 | CID000123703 | |
| Drug | SKF 77434 | 1.82e-07 | 5 | 61 | 3 | CID000001241 | |
| Drug | proterguride | 1.82e-07 | 5 | 61 | 3 | CID000071999 | |
| Drug | NO 756 | 1.82e-07 | 5 | 61 | 3 | CID000129967 | |
| Drug | Levodopa | 1.82e-07 | 5 | 61 | 3 | DB01235 | |
| Drug | SKF85174 | 1.82e-07 | 5 | 61 | 3 | CID000132435 | |
| Drug | l-CSL | 1.82e-07 | 5 | 61 | 3 | CID006918538 | |
| Drug | sibenadet | 1.82e-07 | 5 | 61 | 3 | CID000183811 | |
| Drug | 3-iodobenzamide | 1.82e-07 | 5 | 61 | 3 | CID000202425 | |
| Drug | dazopride | 1.82e-07 | 5 | 61 | 3 | CID000054801 | |
| Drug | azapride | 1.82e-07 | 5 | 61 | 3 | CID003036441 | |
| Drug | piquindone | 1.82e-07 | 5 | 61 | 3 | CID000121903 | |
| Drug | zotepine | 2.03e-07 | 49 | 61 | 5 | CID000005736 | |
| Drug | sulpiride | 2.21e-07 | 96 | 61 | 6 | CID000005355 | |
| Drug | clonidine | 2.47e-07 | 240 | 61 | 8 | CID000002803 | |
| Drug | DAS-431 | 2.70e-07 | 21 | 61 | 4 | CID000166543 | |
| Drug | ziprasidone | 3.04e-07 | 53 | 61 | 5 | CID000060853 | |
| Drug | AC1Q5S71 | 3.55e-07 | 170 | 61 | 7 | CID000000501 | |
| Drug | 2'-ISP | 3.64e-07 | 6 | 61 | 3 | CID000128389 | |
| Drug | Rotigotine | 3.64e-07 | 6 | 61 | 3 | DB05271 | |
| Drug | pyrazole-3 | 3.64e-07 | 6 | 61 | 3 | CID000354929 | |
| Drug | Zuclopenthixol | 3.64e-07 | 6 | 61 | 3 | DB01624 | |
| Drug | pergolide sulfone | 3.64e-07 | 6 | 61 | 3 | CID000155750 | |
| Drug | pergolide sulfoxide | 3.64e-07 | 6 | 61 | 3 | CID000155749 | |
| Drug | A66359 | 3.64e-07 | 6 | 61 | 3 | CID000173657 | |
| Drug | CI-943 | 3.64e-07 | 6 | 61 | 3 | CID000146009 | |
| Drug | AC1L1JFX | 3.64e-07 | 6 | 61 | 3 | CID000005023 | |
| Drug | propylbutyldopamine | 3.64e-07 | 6 | 61 | 3 | CID000156067 | |
| Drug | N,N-dimethyldopamine | 3.64e-07 | 6 | 61 | 3 | CID000152427 | |
| Drug | oxiperomide | 3.64e-07 | 6 | 61 | 3 | CID000068634 | |
| Drug | AC1L1I8U | 3.64e-07 | 6 | 61 | 3 | CID000055036 | |
| Drug | LON-954 | 3.64e-07 | 6 | 61 | 3 | CID006441097 | |
| Drug | p-bromospiperone | 3.64e-07 | 6 | 61 | 3 | CID000156386 | |
| Drug | MDO-NPA | 3.64e-07 | 6 | 61 | 3 | CID000133642 | |
| Disease | hypertension (is_implicated_in) | 1.43e-07 | 121 | 58 | 6 | DOID:10763 (is_implicated_in) | |
| Disease | Recurrent depression | 6.00e-07 | 9 | 58 | 3 | C0221480 | |
| Disease | Depressive disorder | 1.58e-06 | 289 | 58 | 7 | C0011581 | |
| Disease | Mental Depression | 1.07e-05 | 254 | 58 | 6 | C0011570 | |
| Disease | morphine dependence (biomarker_via_orthology) | 1.14e-05 | 3 | 58 | 2 | DOID:2560 (biomarker_via_orthology) | |
| Disease | nephrolithiasis (implicated_via_orthology) | 3.78e-05 | 5 | 58 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | withdrawal disorder (biomarker_via_orthology) | 3.78e-05 | 5 | 58 | 2 | DOID:0060001 (biomarker_via_orthology) | |
| Disease | heroin dependence (biomarker_via_orthology) | 3.78e-05 | 5 | 58 | 2 | DOID:9976 (biomarker_via_orthology) | |
| Disease | Visual seizure | 4.76e-05 | 101 | 58 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 4.76e-05 | 101 | 58 | 4 | C0270846 | |
| Disease | Generalized seizures | 4.76e-05 | 101 | 58 | 4 | C0234533 | |
| Disease | Clonic Seizures | 4.76e-05 | 101 | 58 | 4 | C0234535 | |
| Disease | Vertiginous seizure | 4.76e-05 | 101 | 58 | 4 | C0422855 | |
| Disease | Gustatory seizure | 4.76e-05 | 101 | 58 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 4.76e-05 | 101 | 58 | 4 | C0422850 | |
| Disease | Olfactory seizure | 4.76e-05 | 101 | 58 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 4.76e-05 | 101 | 58 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 4.76e-05 | 101 | 58 | 4 | C4505436 | |
| Disease | Convulsive Seizures | 4.76e-05 | 101 | 58 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 4.76e-05 | 101 | 58 | 4 | C0751496 | |
| Disease | Jacksonian Seizure | 4.76e-05 | 101 | 58 | 4 | C0022333 | |
| Disease | Non-epileptic convulsion | 4.76e-05 | 101 | 58 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 4.76e-05 | 101 | 58 | 4 | C0751123 | |
| Disease | Complex partial seizures | 4.76e-05 | 101 | 58 | 4 | C0149958 | |
| Disease | Single Seizure | 4.76e-05 | 101 | 58 | 4 | C0751110 | |
| Disease | Epileptic Seizures | 4.76e-05 | 101 | 58 | 4 | C4317109 | |
| Disease | Nonepileptic Seizures | 4.76e-05 | 101 | 58 | 4 | C3495874 | |
| Disease | Tonic Seizures | 4.95e-05 | 102 | 58 | 4 | C0270844 | |
| Disease | Absence Seizures | 4.95e-05 | 102 | 58 | 4 | C4316903 | |
| Disease | Convulsions | 4.95e-05 | 102 | 58 | 4 | C4048158 | |
| Disease | Seizures, Focal | 5.34e-05 | 104 | 58 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 5.34e-05 | 104 | 58 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 5.34e-05 | 104 | 58 | 4 | C0494475 | |
| Disease | Pituitary carcinoma | 5.67e-05 | 6 | 58 | 2 | C0346300 | |
| Disease | Seizures | 7.01e-05 | 218 | 58 | 5 | C0036572 | |
| Disease | Pituitary Neoplasms | 1.06e-04 | 8 | 58 | 2 | C0032019 | |
| Disease | Tremor, Neonatal | 1.35e-04 | 9 | 58 | 2 | C0235843 | |
| Disease | Action Tremor | 1.35e-04 | 9 | 58 | 2 | C0234376 | |
| Disease | Passive Tremor | 1.35e-04 | 9 | 58 | 2 | C0234377 | |
| Disease | Static Tremor | 1.35e-04 | 9 | 58 | 2 | C0234378 | |
| Disease | Resting Tremor | 1.35e-04 | 9 | 58 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 1.35e-04 | 9 | 58 | 2 | C0234372 | |
| Disease | Fine Tremor | 1.35e-04 | 9 | 58 | 2 | C0234373 | |
| Disease | Coarse Tremor | 1.35e-04 | 9 | 58 | 2 | C0234374 | |
| Disease | Massive Tremor | 1.35e-04 | 9 | 58 | 2 | C0234375 | |
| Disease | Persistent Tremor | 1.35e-04 | 9 | 58 | 2 | C0234370 | |
| Disease | Continuous Tremor | 1.35e-04 | 9 | 58 | 2 | C0234371 | |
| Disease | Darkness Tremor | 1.35e-04 | 9 | 58 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 1.35e-04 | 9 | 58 | 2 | C1527384 | |
| Disease | Tremor, Perioral | 1.35e-04 | 9 | 58 | 2 | C0235078 | |
| Disease | Nerve Tremors | 1.35e-04 | 9 | 58 | 2 | C0235083 | |
| Disease | Tremor, Limb | 1.35e-04 | 9 | 58 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 1.35e-04 | 9 | 58 | 2 | C0235082 | |
| Disease | Senile Tremor | 1.35e-04 | 9 | 58 | 2 | C0149840 | |
| Disease | Saturnine Tremor | 1.35e-04 | 9 | 58 | 2 | C0040827 | |
| Disease | Pill Rolling Tremor | 1.35e-04 | 9 | 58 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 1.35e-04 | 9 | 58 | 2 | C0751565 | |
| Disease | Pituitary Adenoma | 1.35e-04 | 9 | 58 | 2 | C0032000 | |
| Disease | depressive disorder (biomarker_via_orthology) | 1.49e-04 | 52 | 58 | 3 | DOID:1596 (biomarker_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 1.84e-04 | 268 | 58 | 5 | C0001973 | |
| Disease | Tremor | 2.06e-04 | 11 | 58 | 2 | C0040822 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.62e-04 | 157 | 58 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | Schizophrenia | 3.18e-04 | 883 | 58 | 8 | C0036341 | |
| Disease | Bipolar Disorder | 3.44e-04 | 477 | 58 | 6 | C0005586 | |
| Disease | Waxy flexibility | 3.92e-04 | 15 | 58 | 2 | C0233612 | |
| Disease | Dyskinesia, Drug-Induced | 3.92e-04 | 15 | 58 | 2 | C0013386 | |
| Disease | Dyskinesia, Medication-Induced | 3.92e-04 | 15 | 58 | 2 | C0751088 | |
| Disease | Catalepsy | 3.92e-04 | 15 | 58 | 2 | C0007370 | |
| Disease | Lipidemias | 5.07e-04 | 17 | 58 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 5.07e-04 | 17 | 58 | 2 | C0020473 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 6.36e-04 | 19 | 58 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | sleep duration | 7.27e-04 | 362 | 58 | 5 | EFO_0005271 | |
| Disease | obesity (is_implicated_in) | 7.74e-04 | 91 | 58 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 7.78e-04 | 21 | 58 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | Attention Deficit Disorder | 8.55e-04 | 22 | 58 | 2 | C0041671 | |
| Disease | depressive disorder (implicated_via_orthology) | 8.55e-04 | 22 | 58 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | Minimal Brain Dysfunction | 8.55e-04 | 22 | 58 | 2 | C1321905 | |
| Disease | Etat Marbre | 9.36e-04 | 23 | 58 | 2 | C0266487 | |
| Disease | Attention deficit hyperactivity disorder | 1.02e-03 | 24 | 58 | 2 | C1263846 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 1.02e-03 | 24 | 58 | 2 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | opioid use disorder | 1.05e-03 | 101 | 58 | 3 | EFO_0010702 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.24e-03 | 107 | 58 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Myocardial Failure | 1.34e-03 | 110 | 58 | 3 | C1959583 | |
| Disease | Congestive heart failure | 1.34e-03 | 110 | 58 | 3 | C0018802 | |
| Disease | Heart failure | 1.34e-03 | 110 | 58 | 3 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.34e-03 | 110 | 58 | 3 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.34e-03 | 110 | 58 | 3 | C0235527 | |
| Disease | Heart Decompensation | 1.34e-03 | 110 | 58 | 3 | C1961112 | |
| Disease | Movement Disorders | 1.49e-03 | 29 | 58 | 2 | C0026650 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 1.59e-03 | 30 | 58 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | proteinuria (implicated_via_orthology) | 1.59e-03 | 30 | 58 | 2 | DOID:576 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 1.65e-03 | 257 | 58 | 4 | DOID:10652 (is_marker_for) | |
| Disease | Hyperkinesia, Generalized | 1.81e-03 | 32 | 58 | 2 | C0751217 | |
| Disease | Hyperkinesia | 1.81e-03 | 32 | 58 | 2 | C3887506 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAAFYLPVVIMTVLY | 201 | P08173 | |
| VSFYVPLVIMVFVYS | 206 | P07550 | |
| YMTPVILLVFALALY | 896 | O43306 | |
| VIFLYIFILFIMLYP | 1111 | Q9H7F0 | |
| IYDMVFYLVPVAFSI | 2036 | Q86UK0 | |
| YIFVMIPTLYSIIFV | 26 | P30556 | |
| YMISFLPYIVLLVLH | 3686 | Q86UQ4 | |
| ISFYIPVAIMIVTYT | 201 | P21728 | |
| VSFYLPLLVMLFVYA | 211 | P13945 | |
| LISFYIPVAIMIVTY | 231 | P21918 | |
| HILPYFYIIYFTMLL | 566 | Q14739 | |
| ITIVVLMFGPSIYIY | 246 | A0A0X1KG70 | |
| VFYTTVILMLNPLIY | 276 | Q8NGM9 | |
| VVSMIFVPSIYLYAR | 246 | P58180 | |
| LTVVVIFYGTILFMY | 246 | P0DN81 | |
| VTIFYGTIIFMYLQP | 251 | Q8NGZ5 | |
| MTIVAFLVYFIPLTI | 211 | Q6W5P4 | |
| FLVYFIPLTIISIMY | 216 | Q6W5P4 | |
| DYILITIIIMYFIFT | 366 | Q9NUN5 | |
| ILILTFYTAIMVPYN | 221 | Q8NCM2 | |
| VFYSIITLMLNPLIY | 271 | Q8NH70 | |
| VLIFYVTVMGLTFIY | 246 | Q9Y5P1 | |
| ITIVVLMFGPSIYIY | 246 | Q8NGD0 | |
| ITIVVLMFGPSIYIY | 246 | Q8NGB6 | |
| KYFPYLVVIHTLIFM | 116 | Q6NSJ5 | |
| LIIGYSTIYTMFPVF | 876 | O75110 | |
| PLFFLFLVVYIVTMV | 26 | Q8NGG8 | |
| TPVLTLLFVVIMYQY | 11 | Q8IZP7 | |
| VVLLFYGTIMSPYFR | 246 | Q96R84 | |
| MLLIPVTVISVSYYY | 206 | Q8NGZ9 | |
| AKMYSLFYTIIIPLL | 271 | P0C628 | |
| SLGMLYVPKTYVILF | 831 | O15303 | |
| LVFMVPFYIGYFIVS | 86 | B7ZAQ6 | |
| LVFMVPFYIGYFIVS | 86 | P0CG08 | |
| KILFYISIFSYPELM | 66 | Q5K131 | |
| LVFYVIPLSIISVYY | 216 | P30550 | |
| YYLIQMYIPSLLIVI | 256 | P23416 | |
| VSFYVPFIVTLLVYI | 196 | P14416 | |
| TLYFLVLLPFFMILV | 6 | Q16602 | |
| VIALIYFLPLAVMFV | 201 | P21452 | |
| YFLPLAVMFVAYSVI | 206 | P21452 | |
| FSYPFLVLQMYVLTL | 111 | Q6ZN68 | |
| PVFFIFLLFYLLILM | 31 | A6NND4 | |
| IFLFYITVIIMYIRP | 246 | Q8NGF7 | |
| PLFFLFLVIYIVTMV | 26 | Q96RD0 | |
| METVLTIIALFYYPL | 196 | Q92521 | |
| MVYFLPIIFSILVVF | 1 | P0DSN6 | |
| MVLVPIYVIYKFLST | 566 | P23975 | |
| YFSATYPYIMLIILF | 241 | P30531 | |
| YPYIMLIILFFRGVT | 246 | P30531 | |
| IYYPMLVVILCIATY | 531 | Q68DH5 | |
| LTSYKVIYVLPMLTI | 366 | Q9P2J5 | |
| VFYTVVIPMLNSVIY | 276 | Q8NGL2 | |
| IEPLIVFMFSYLSYL | 301 | Q6AI14 | |
| IIAMVVYTAYVFIPI | 41 | Q8NFR3 | |
| FYTTVIPMLNLIIYS | 276 | Q8NGP6 | |
| PQMEIIFFVVFLIVY | 21 | Q8NGP9 | |
| VTVTIFYGTLIFMYL | 246 | Q8NH85 | |
| FYMLIILPFLILLVF | 191 | Q495N2 | |
| FFLIIYITMTYTRIP | 86 | Q8IZV2 | |
| FRKLIYYIIFSIIML | 91 | Q9BU79 | |
| DLYIPAMAFITYVLV | 156 | Q5BJH7 | |
| MTTQLPAYVAILLFY | 1 | O95497 | |
| VFYVLSYLQPAMAVI | 111 | Q9BS91 | |
| LIVYYPVFLVMTSSA | 241 | Q9NYW1 | |
| IRVIEPLFVFLYSYM | 326 | P19634 | |
| DVYYYRIIIPVLLML | 486 | Q86Y07 | |
| LMVYFLILYIPYSVA | 231 | Q9NYW5 | |
| YFPYLVLIHTLVFML | 126 | Q8TDW0 |